GB Sciences, Inc.
GBLX
$0.0002
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 33.16% | 38.97% | -149.33% | 56.86% | -58.99% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -30.97% | 2.65% |
| Total Other Non-Cash Items | -- | -- | 100.00% | -437.97% | -137.44% |
| Change in Net Operating Assets | -68.52% | 22.55% | 281.85% | 154.30% | -79.89% |
| Cash from Operations | -389.55% | 91.29% | -22.93% | 50.21% | -291.74% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -63.83% | -- |
| Cash from Investing | -- | -- | -100.00% | -63.83% | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | 100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -84.88% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | 1,000.00% | -95.95% | 641.74% | -86.81% | 909.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.17% | -118.18% | 93.69% | -216.29% | 193.28% |